Aduro Biotech Receives Milestone Payment From Janssen for Submission of Investigational New Drug Application for ADU-214 in Lung Cancer
October 08, 2015 at 16:00 PM EDT
Aduro Biotech, Inc. (Nasdaq: ADRO) today announced that it has received a milestone payment from Janssen Biotech, Inc. for Aduro's ...
